Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
The Prostate
|
June 29, 2022
Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer
Takafumi Yanagisawa, Takahiro Kimura, Kenichi Hata, et al.
Clinical Genitourinary Cancer
|
April 4, 2026
Clinical Characteristics and Predictive Factors of Symptomatic Skeletal Events in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Denosumab
Yuzo Inaba, Fumihiko Urabe, Yu Imai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 16, 2025
Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First-Line Platinum-Based Chemotherapy: A Multicenter Collaborative Study
Fumihiko Urabe, Kojiro Tashiro, Yu Imai, et al.
Prostate International
|
April 11, 2025
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study
Fumihiko Urabe, Hirokazu Kagawa, Takafumi Yanagisawa, et al.
Japanese Journal of Clinical Oncology
|
April 8, 2025
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study
Fumihiko Urabe, Yuki Taneda, Naoki Uchida, et al.
Clinical Genitourinary Cancer
|
May 10, 2025
Optimal Cystoscopic Surveillance Schedule Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Yuhei Koike, Fumihiko Urabe, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology
|
January 25, 2026
Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomy
Miyaka Umemori, Shun Sato, Fumihiko Urabe, et al.
Urologic Oncology
|
March 1, 2025
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter study
Fumihiko Urabe, Kojiro Tashiro, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology
|
January 17, 2025
Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative study
Yuki Taneda, Fumihiko Urabe, Naoki Uchida, et al.
Urologic Oncology
|
May 19, 2026
Beyond PSA90: Deep PSA response predicts outcomes in nonmetastatic CRPC
Shuhei Hara, Keiichiro Mori, Ryotaro Yamaguchi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
The Prostate
|
June 29, 2022
Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer
Takafumi Yanagisawa, Takahiro Kimura, Kenichi Hata, et al.
Clinical Genitourinary Cancer
|
April 4, 2026
Clinical Characteristics and Predictive Factors of Symptomatic Skeletal Events in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Denosumab
Yuzo Inaba, Fumihiko Urabe, Yu Imai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 16, 2025
Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First-Line Platinum-Based Chemotherapy: A Multicenter Collaborative Study
Fumihiko Urabe, Kojiro Tashiro, Yu Imai, et al.
Prostate International
|
April 11, 2025
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study
Fumihiko Urabe, Hirokazu Kagawa, Takafumi Yanagisawa, et al.
Japanese Journal of Clinical Oncology
|
April 8, 2025
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study
Fumihiko Urabe, Yuki Taneda, Naoki Uchida, et al.
Clinical Genitourinary Cancer
|
May 10, 2025
Optimal Cystoscopic Surveillance Schedule Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Yuhei Koike, Fumihiko Urabe, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology
|
January 25, 2026
Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomy
Miyaka Umemori, Shun Sato, Fumihiko Urabe, et al.
Urologic Oncology
|
March 1, 2025
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter study
Fumihiko Urabe, Kojiro Tashiro, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology
|
January 17, 2025
Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative study
Yuki Taneda, Fumihiko Urabe, Naoki Uchida, et al.
Urologic Oncology
|
May 19, 2026
Beyond PSA90: Deep PSA response predicts outcomes in nonmetastatic CRPC
Shuhei Hara, Keiichiro Mori, Ryotaro Yamaguchi, et al.
Page
of 3